About Porton Biopharma

A long history of pharmaceutical development.

 

We specialise in the development and manufacture of biopharmaceuticals for niche indications.

Our History

Located in the heart of Wiltshire, Porton Biopharma has a rich history in the development and manufacture of biopharmaceuticals for a wide variety of diseases.

  • 1951 — MoD Microbiological Research Establishment opened
  • 1979 — Ownership passed to the UK government Department of Health & Anthrax Vaccine licensed in the UK
  • 1985 — Erwinase first licensed in the UK
  • 2013 — The site became the centre of Public Health England
  • 2015 — PBL spun out of PHE to run as a commercial entity, whilst still owned by the Department of Health

 

Anthrax Vaccine

We  manufacture the UK’s licensed anthrax vaccine. It is supplied for both occupational health purposes and to protect those at risk from the use of anthrax as a biological weapon.

 

Erwinase (Crisantaspase)

Developed at Porton in the 1960’s, PBL remains the sole global manufacturer of Erwinase® which was first registered as a product name in the UK in 1985. Since then it has been supplied to treat haematological malignancies around the world.

Learn more

Registered in England and Wales, company number 9331560. Registered office at Manor Farm Road, Porton Down, Salisbury, Wiltshire SP4 0JG. VAT number is GB 206 6518 18.